Trials Sponsors Conditions Drugs Pricing

Conditions

Heart Failure

Outcome Measures

Primary Outcomes (1)

Quality of life (Minnesota Living with Heart Failure Questionnaire)
Quality of life will be measured through Minnesota Living with Heart Failure Questionnaire (MLHFQ). It is one of the most widely used health-related quality of life questionnaires for individuals with HF. It provides scores for two dimensions, physical and emotional, and a total score. The MLHFQ is a self-administered, 21-item disease-specific instrument for individuals with HF. Each item is scored in a 6-point Likert Scale (0 to 5), thus the total score could range from 0 to 105, with higher scores indicating more significant impairment in health-related quality of life. The MLHFQ has two domains; physical domain (eight items, score range from 0 to 40) and emotional domain (five items, score range from 0 to 25).
6 months

Secondary Outcomes (2)

Reliability of translated versions of Minnesota Living with Heart Failure Questionnaire
6 months
Validity of translated versions of Minnesota Living with Heart Failure Questionnaire
6 months

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Heart Failure individuals

You may qualify if:

Patients with chronic heart failure who sought treatment at the outpatient cardiology clinic.

Sponsors & Collaborators

Riphah International University
Otherlead

Study Sites (1)

Railway General Hospital

Rawalpindi, Punjab Province, 46000, Pakistan

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

Muhammad Iqbal Tariq, PhD*
Riphah International University
PRINCIPAL INVESTIGATOR
Arshad Nawaz Malik, PhD
Riphah International University
STUDY CHAIR
Shane Patman, PhD
University of Notre Dame Australia
STUDY CHAIR

Enrollment

210 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 4, 2023

First Posted

October 10, 2023

Study Start

November 12, 2023

Actual (reported)

Urdu Translation and Validation of MLHFQ

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations